Ernst & Young undertook consultations with representatives from peak bodies and sought specific information from state and territory jurisdictions. The purpose of the consultations was to assess the degree to which the National Service Improvement Framework for Heart, Stroke and Vascular Disease was understood and utilised across the system, to gain an understanding of programs in place and to discuss gaps or areas for greater attention moving forward.
9.1 Review Advisory GroupTo ensure access to expert guidance during the course of the Review, a Review Advisory Group was established. The Review Advisory Group membership list is contained in the Terms of Reference at Appendix B. Proposed Review Advisory Group members were contacted and alternatives chosen where initial nominees were unable to participate.
The Review Advisory Group met twice by phone; at the first meeting, held on the 15th January 2009 a draft Progress Report was discussed and at the second meeting on the 12th February 2009 the draft Final Report was discussed. Out of session feedback from some Review Advisory Group members was sought on their specific areas of expertise.
9.2 MeetingsThe Ernst & Young team has consulted with representatives of the following key stakeholders:
- Departments of Health/Human Services in States/Territories
- The National Heart Foundation (NHF)
- The National Stroke Foundation (NSF)
- The National Aboriginal Community Controlled Health Organisation (NACCHO)
- The Australian General Practice Network (AGPN)
- The Royal Australian College of General Practitioners (RACGP)
- The Australian Health Insurance Association (AHIA)
- Kidney Health Australia
- The Australian Diabetes Society
- The Baker IDI Heart and Diabetes Institute (Indigenous Division)
- Australian Primary Care Collaboratives
- Australian Commission on Safety and Quality in Health Care
- National Institute of Clinical Studies
- Members of the Review Advisory Group